Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
SARSF: inactive security. FINRA deleted symbol:
https://otce.finra.org/otce/dailyList?viewType=Deletions
So, what’s the deal with this company? Is it legitimate or a scam?
Expanding beyond canada , lots to like with this group no one knows about them because they didnt make the Pump Train
https://finance.yahoo.com/news/abba-medix-signs-medical-cannabis-135000469.html
The people running this company are apparently smart people although the stock has been shit. I'm really curious to see what happens.
Abba Medix Corp. Signs Exclusive Licensing Agreement with Santa Cruz Medicinals
he agreement is aligned to Canada House Wellness Group's Health and Wellness strategy for the Canadian adult-use market
https://www.newswire.ca/news-releases/abba-medix-corp-signs-exclusive-licensing-agreement-with-santa-cruz-medicinals-806168226.html
Canada House Wellness Group Inc. Announces Full Operations in its Facility, Commences Full-Scale Production of EU-GMP Certified Cannabis
36 mil market cap on a company with full tilt EU-GMP facility and sales license , plus there are only 8 EU GMP facilities in Canada- Aurora has 2 - Emblem has 1 - CHV has 1 - they will get absorbed by a big player for sure
Canada House Elevator Pitch Estimates for year 2019
2700 kgs production @avg $8/ gram = $21.6 million
Retail based on the one Edmonton store = $6 million / year
Knalysis = 0.5 million (uncertain)
Canada House clinics = $5 million (factoring in recent growth)
TOTAL revenue projected $38.1 million
Earnings @ a net margin of 25% = $9.53 million
EPS $9.53 million ebitda / 200 million shares = $0.047/ share
Price target @ multiple of 20 = 0.94 cents share price
Seeking Alpha article on Canada House. https://seekingalpha.com/instablog/17663872-dean-chaykowski/5229065-canada-house-elevator-pitch
If there isn´t good news potential in the pipeline they would not hire Marigold for promotion
Lets see where the journey goes today...
Yesterday with +57,8% to 0,355 CAD the Top-Performer in Pot-Sector!
Todays PR means they hired Marigold for better PR!
https://web.tmxmoney.com/article.php?newsid=8076119846171312&qm_symbol=CHV:CNX
A brief overview of CHV SARSF
who recently received their license to sell
https://ryghub.com/2018/08/05/canada-house-wellness-a-brief-overview/
Brief overview of CHV SARSF who recently received their license to sell
https://ryghub.com/2018/08/05/canada-house-wellness-a-brief-overview/
$CHV Received their Licence to Sell Medical Marijuana yesterday.
Their market cap seems very low compared to the others.
Latest $CHV Tweets worthy of mentioning:
https://twitter.com/cpalms_walru…/status/1025515061870256133
https://twitter.com/polish_man23/status/1025516102598701057
Congratulations to the team over at @CanadaHouse for getting their sales license. Bright future ahead for you guys.#Cannabis #PotStocks $CHV
— Follow The Money Investor Group (@FTMInvest) August 3, 2018
Congrats to @Abbamedixgroup and @CanadaHouse $CHV for your sales license awarded today on #ACMPRfriday #MarijuanaStocks #investing pic.twitter.com/CliSNyqbfh
— Unsweetened (@bittertweeties) August 3, 2018
Canada House Wellness DD
CHV/SARSF doesn't seem to be mentioned here much, so I thought I would open up a discussion, and have everyone thoughts around it.
CHV/SARSF have 3 divisions with (11) clinics and additional 4 more soon, growing, and tech which are Marijuana for Trauma Cannabis Wellness Clinics, Abba Medix Corp. Licensed Producer and Knalysis Technologies Data Analytics.
Marijuana for Trauma Cannabis Wellness Clinics provide services to its clients include:
• Documentation of a client’s medical history and current condition;
• Evaluation of their current condition and meds taken;
• Discussion of possible cannabis alternatives to consider;
• Assistance in obtaining a medical cannabis prescription;
• Assistance in identifying a “best fit” cannabis strain and vendor selection;
• Evaluation of treatment results, with the objective of establishing each client’s optimum benefit routine; and
• Counseling on how a client can take full advantage of any insurance and disability benefits that may be available.
Abba Medix Craft Cannabis Licensed Producer: Abba projects that it will complete its required two grow cycles and will have received its License to Sell and be fully operational by the end of Q2 2018, at a cost of approximately $5 million, a significant portion of which is already in place.
Abba will then offer a fully integrated seed to sale vertical with the benefit of an API that will link directly to the Cannabis Patient Management patient services and software provided by its sister company, Marijuana for Trauma – now with more than 7,000 active clients.
They have been issued permits from Health Canada and the Canadian Food Inspection Agency to import its selected starting genetics.
These genetics are scheduled to arrive in February. Abba looks to have two lots of cannabis harvested and ready for Health Canada approval by the end of June and anticipates receiving a License to Sell by July. Abba then expects to be in full production by September of this year.
At full production, Abba’s current grow operations are projected to produce more than 2,100 kg annually.
Knalysis Technologies Data Analytics: It created its smartphone Wellness Tracker to provide an essential treatment-results-treatment refinement feedback loop to refine its data sets.
For its sister company, MFT, it created its HIPPA-compliant Cannabis Patient Management software that seamlessly links MFT with its patients, physicians, and other care providers, a global approach to reporting, monitoring and care. Its leadership team envisioned a need for health technology connecting every aspect of the medical marijuana field, and has pioneered software developed to deliver better monitoring of symptoms, moods, and treatments for both physician and patient. Knalysis principals are industry veterans in technology, data collection, business applications, and the medical marijuana vertical
Has more than 12,000 medical cannabis patients on its software platforms representing 6% of the registered base in all of Canada. Coupled with Knalysis’ US client base, more than 32 million data points for medical cannabis treatment have been captured to date.
As patient count in the Knalysis platforms continues to increase by approximately 2,500 per month, it is now seeing the impact of having big data at its fingertips.
Knalysis is also gaining traction with several potential new cannabis clinic clients which would add another 10,000 – 20,000 patients into its platforms by mid-year, adding 10s of millions more data points for the benefit of its analytics subscribers.
CHV also expects license to sell, and applied for extraction license.
Canada House wellness has the lowest market cap of all companies waiting to recieve there sales LIC
Not sure if the community is aware, but WhiteSheep Corp tracks the amount of days it takes LPs to get their Sales License after receiving their Cultivation License.
https://imgur.com/JZJt4hK
Days since cultivation license received- along with stock ticker
VIDEO: Canada House Wellness is a Fully Integrated Company that Validates Medical Patients
https://www.midasletter.com/2018/02/video-canada-house-wellness-fully-integrated-company-validates-medical-patients/
FB investors Group Link:
https://www.facebook.com/groups/chvinvestorsgroup/
Feel free to join!
Go CHV! :)
Amazing thanks for joining the party. (CHV) or (SARSF) is UnderValued and gonna be $2-$3 with sales license.
- 3 amazing Divisions
- Abba Medix: Cultivation license - Soon to have Sales License, extraction etc.!
- Marijuana for Trauma - 11 medical Marijuana clinics aimed at Veterans. 4 more to come.
- Knalysis Technologies - Tech for the MJ space.
See Article: http://thedeepdive.ca/canada-house-wellness-undervalued/
Canada House Wellness – The Undervalued Cannabis Player
Here is some DD
Robertson15 wrote:
Hey guys, heres a due diligence write up on CHV to keep on your radar!
CHV Sp is .46 Trading. Cultivation license already with sales license on the way! Theyre applying for an extraction license this week also. Including a joint venture for edibles and oil with EAT (Nutritional High)...Also in talks to expand to a possible 90k sqf at their current leased property or aquiring elsewhere!
Canada House Wellness Group Inc
CHV have 3 divisions with (11) clinics and additional 4 more soon, growing, and tech which are Marijuana for Trauma Cannabis Wellness Clinics, Abba Medix Corp. Licensed Producer and Knalysis Technologies Data Analytics.
Marijuana for Trauma Cannabis Wellness Clinics provide services to its clients include:
• Documentation of a client’s medical history and current condition;
• Evaluation of their current condition and meds taken;
• Discussion of possible cannabis alternatives to consider;
• Assistance in obtaining a medical cannabis prescription;
• Assistance in identifying a “best fit” cannabis strain and vendor selection;
• Evaluation of treatment results, with the objective of establishing each client’s optimum benefit routine; and
• Counseling on how a client can take full advantage of any insurance and disability benefits that may be available.
Abba Medix Craft Cannabis Licensed Producer: Abba projects that it will complete its required two grow cycles and will have received its License to Sell and be fully operational by the end of Q2 2018, at a cost of approximately $5 million, a significant portion of which is already in place.
Abba will then offer a fully integrated seed to sale vertical with the benefit of an API that will link directly to the Cannabis Patient Management patient services and software provided by its sister company, Marijuana for Trauma – now with more than 7,000 active clients.
They have been issued permits from Health Canada and the Canadian Food Inspection Agency to import its selected starting genetics.
These genetics are scheduled to arrive in February. Abba looks to have two lots of cannabis harvested and ready for Health Canada approval by the end of June and anticipates receiving a License to Sell by July. Abba then expects to be in full production by September of this year.
At full production, Abba’s current grow operations are projected to produce more than 2,100 kg annually.
Knalysis Technologies Data Analytics: It created its smartphone Wellness Tracker to provide an essential treatment-results-treatment refinement feedback loop to refine its data sets.
For its sister company, MFT, it created its HIPPA-compliant Cannabis Patient Management software that seamlessly links MFT with its patients, physicians, and other care providers, a global approach to reporting, monitoring and care. Its leadership team envisioned a need for health technology connecting every aspect of the medical marijuana field, and has pioneered software developed to deliver better monitoring of symptoms, moods, and treatments for both physician and patient. Knalysis principals are industry veterans in technology, data collection, business applications, and the medical marijuana vertical
Has more than 12,000 medical cannabis patients on its software platforms representing 6% of the registered base in all of Canada. Coupled with Knalysis’ US client base, more than 32 million data points for medical cannabis treatment have been captured to date.
As patient count in the Knalysis platforms continues to increase by approximately 2,500 per month, it is now seeing the impact of having big data at its fingertips.
Knalysis is also gaining traction with several potential new cannabis clinic clients which would add another 10,000 – 20,000 patients into its platforms by mid-year, adding 10s of millions more data points for the benefit of its analytics subscribers.
CHV also expects license to sell, and applied for extraction license.
Joined you MrPojax!!!
SARSF
$SARSF or $CHV Sp is .46 Trading. Cultivation license already with sales license on the way! Canada House Wellness Group Inc
CHV have 3 divisions with (11) clinics and additional 4 more soon, growing, and tech which are Marijuana for Trauma Cannabis Wellness Clinics, Abba Medix Corp. Licensed Producer and Knalysis Technologies Data Analytics.
Marijuana for Trauma Cannabis Wellness Clinics provide services to its clients include:
• Documentation of a client’s medical history and current condition;
• Evaluation of their current condition and meds taken;
• Discussion of possible cannabis alternatives to consider;
• Assistance in obtaining a medical cannabis prescription;
• Assistance in identifying a “best fit” cannabis strain and vendor selection;
• Evaluation of treatment results, with the objective of establishing each client’s optimum benefit routine; and
• Counseling on how a client can take full advantage of any insurance and disability benefits that may be available.
Abba Medix Craft Cannabis Licensed Producer: Abba projects that it will complete its required two grow cycles and will have received its License to Sell and be fully operational by the end of Q2 2018, at a cost of approximately $5 million, a significant portion of which is already in place.
Abba will then offer a fully integrated seed to sale vertical with the benefit of an API that will link directly to the Cannabis Patient Management patient services and software provided by its sister company, Marijuana for Trauma – now with more than 7,000 active clients.
They have been issued permits from Health Canada and the Canadian Food Inspection Agency to import its selected starting genetics.
These genetics are scheduled to arrive in February. Abba looks to have two lots of cannabis harvested and ready for Health Canada approval by the end of June and anticipates receiving a License to Sell by July. Abba then expects to be in full production by September of this year.
At full production, Abba’s current grow operations are projected to produce more than 2,100 kg annually.
Knalysis Technologies Data Analytics: It created its smartphone Wellness Tracker to provide an essential treatment-results-treatment refinement feedback loop to refine its data sets.
For its sister company, MFT, it created its HIPPA-compliant Cannabis Patient Management software that seamlessly links MFT with its patients, physicians, and other care providers, a global approach to reporting, monitoring and care. Its leadership team envisioned a need for health technology connecting every aspect of the medical marijuana field, and has pioneered software developed to deliver better monitoring of symptoms, moods, and treatments for both physician and patient. Knalysis principals are industry veterans in technology, data collection, business applications, and the medical marijuana vertical
Has more than 12,000 medical cannabis patients on its software platforms representing 6% of the registered base in all of Canada. Coupled with Knalysis’ US client base, more than 32 million data points for medical cannabis treatment have been captured to date.
As patient count in the Knalysis platforms continues to increase by approximately 2,500 per month, it is now seeing the impact of having big data at its fingertips.
Knalysis is also gaining traction with several potential new cannabis clinic clients which would add another 10,000 – 20,000 patients into its platforms by mid-year, adding 10s of millions more data points for the benefit of its analytics subscribers.
CHV also expects license to sell, and applied for extraction license.
Followers
|
2
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
33
|
Created
|
01/24/18
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |